Association between lipid profile and silent coronary artery disease in south Indian patients with type 2 diabetes mellitus

Bhutto M. G., Lokesh M. R., Sharath Kumar D. Shah, Afroze M. K. H., Ghouse P., Abhilash D.


Background: The patients with type 2 diabetes have an increased prevalence of lipid abnormalities (Dyslipidemia). Early diagnosis of diabetic patients with silent CAD and dyslipidemia can reduce the morbidity and mortality for cardiovascular death. The objective of the present study is to assess the prevalence of silent coronary disease among south Indian type-2 diabetic patients without cardiovascular symptoms and association between lipid profile and silent coronary disease among them.

Methods: 100 Type 2 diabetes mellitus patients (65 males and 35 females) of age 40-80 years attending the OPD of Sri Siddhartha Medical College, Tumakuru, Karnataka, Indiawere enrolled in this study. The Serum samples were analysed for fasting blood glucose (FBS), post prandial blood glucose (PPBS), HbA1c, and lipid profile. The patients were classified into CAD and Non CAD groups based on ECG changes and stress test. Results were analysed SPSS 16.0 software.

Results: The study revealed that 46% of our study population had silent CAD. The prevalence of dyslipidemia was found higher in males than females in both study groups. CAD group patients had significantly higher levels of serum total cholesterol, triglycerides, LDL- cholesterol and low HDL - cholesterol compared to Non CAD group.

Conclusions: Dyslipidemia is indicating the strong association with silent CAD in type 2 diabetes mellitus. It is also advisable to have a screening ECG for silent CAD at the time of diagnosis or during the follow-up period in type 2 diabetes.


Dyslipidemia, Lipid profile, Silent coronary artery disease, Type 2 diabetes mellitus

Full Text:



Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care. 1979;2:120-6.

Sekhri T, Kanwar RS, Wilfred R, Chugh P, Chhillar M, Aggarwal R, et al. Prevalence of risk factors for coronary artery disease in an urban Indian population. BMJ Open. 2014;4:e005346.

Michael FZ, Matthias EP. Silent coronary artery disease in patients with diabetes mellitus. Swiss Med Wkly. 2011;131:427-32.

Nesto RW. Screening for asymptomatic coronary artery disease in diabetes. Diabetes Care. 1999;22:1393-5.

Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. American Diabetes Association. Diabetes Care. 1998;21(9):1551-9.

Srinivasan MP, Kamath PK, Bhat NM, Pai ND, Bhat RU, Shah TD, et al. Severity of coronary disease in type 2 diabetes mellitus: does the timing matter? Indian Heart J. 2016;68:158-63.

Koistinen MJ. Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. BMJ. 1990;301:92-5.

Meenu J. Correlation between HbA1c values and lipid profile in type 2 diabetes mellitus. Int J Basic App Physiol. 2013;2(1):47-50.

Chandra KP, Shukla DK. Prospective study of blood lipid parameters in patients with type 2 diabetes mellitus and its correlation with glycated hemoglobin. Int J Adv Med. 2016;3(3):542-5.

Uttra KM, Devrajani BR, Shah SZA, Devrajani T, Das T, Raza S. Lipid profile of patients with Diabetes mellitus. World Appl Sci J. 2011;12(9):1382-4.

Ahmad A, Khan AR, Raja ZA, Mustafa G., Measurement of serum cholesterol and triglyceride: evaluation in patients with diabetes, hypertension and cerebrovascular accidents in South Punjab. Professional. 2003;10(2):92-8.

Ibrahim M, Shaheenb K, Nourc MA. Lipid profile in Egyptian patients with coronary artery disease. The Egyptian Heart J. 2013;65:79-85.

Vinter-Repalust N, Jurković L, Katić M, Simunović R, Petric D. The disease duration, patient compliance and the presence of complications in diabetic patients. Acta Med Croatica. 2007;61(1):57-62.

Mahato RV, Gyawali P, Raut P, Regmi P, Singh K, Pandeya DR, et al. Association between glycaemic control and serum lipid profile in type 2 diabetic patients: glycated haemoglobin as a dual biomarker. Biomed Res. 2011;22(3):375-80.

Singh G, Kumar AK. A study of lipid profile in type 2 diabetic Punjabi population. J Exe Sci Physiother. 2012;8(1):7-10.